123 related articles for article (PubMed ID: 2000934)
1. Effects of the phospholipase inhibitor mepacrine on injury in ischemic and metabolically inhibited adult isolated myocytes.
Armstrong SC; Ganote CE
Am J Pathol; 1991 Mar; 138(3):545-55. PubMed ID: 2000934
[TBL] [Abstract][Full Text] [Related]
2. Irreversible injury of isolated adult rat myocytes. Osmotic fragility during metabolic inhibition.
Ganote CE; Vander Heide RS
Am J Pathol; 1988 Aug; 132(2):212-22. PubMed ID: 3400772
[TBL] [Abstract][Full Text] [Related]
3. Effect of osmotic stress on sarcolemmal integrity of isolated cardiomyocytes following transient metabolic inhibition.
Ruiz-Meana M; García-Dorado D; González MA; Barrabés JA; Soler-Soler J
Cardiovasc Res; 1995 Jul; 30(1):64-9. PubMed ID: 7553725
[TBL] [Abstract][Full Text] [Related]
4. Effects of the protein phosphatase inhibitors okadaic acid and calyculin A on metabolically inhibited and ischaemic isolated myocytes.
Armstrong SC; Ganote CE
J Mol Cell Cardiol; 1992 Aug; 24(8):869-84. PubMed ID: 1331472
[TBL] [Abstract][Full Text] [Related]
5. Mepacrine, a phospholipase inhibitor. A potential tool for modifying myocardial reperfusion injury.
Otani H; Engelman RM; Breyer RH; Rousou JA; Lemeshow S; Das DK
J Thorac Cardiovasc Surg; 1986 Aug; 92(2):247-54. PubMed ID: 3736082
[TBL] [Abstract][Full Text] [Related]
6. Association between inhibition of arachidonic acid release and prevention of calcium loading during ATP depletion in cultured rat cardiac myocytes.
Jones RL; Miller JC; Hagler HK; Chien KR; Willerson JT; Buja LM
Am J Pathol; 1989 Sep; 135(3):541-56. PubMed ID: 2506756
[TBL] [Abstract][Full Text] [Related]
7. Effects of angiotensin II on intracellular calcium and contracture in metabolically inhibited cardiomyocytes.
Boston DR; Koyama T; Rodriguez-Larrain J; Zou A; Su Z; Barry WH
J Pharmacol Exp Ther; 1998 May; 285(2):716-23. PubMed ID: 9580618
[TBL] [Abstract][Full Text] [Related]
8. Effects of 2,3-butanedione monoxime (BDM) on contracture and injury of isolated rat myocytes following metabolic inhibition and ischemia.
Armstrong SC; Ganote CE
J Mol Cell Cardiol; 1991 Sep; 23(9):1001-14. PubMed ID: 1942093
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric analysis of isolated adult cardiomyocytes: vinculin and tubulin fluorescence during metabolic inhibition and ischemia.
Armstrong SC; Ganote CE
J Mol Cell Cardiol; 1992 Feb; 24(2):149-62. PubMed ID: 1583698
[TBL] [Abstract][Full Text] [Related]
10. Effects of calcium depletion and loading on injury during metabolic inhibition of isolated adult rat myocytes.
Rim DS; Altschuld RA; Ganote CE
J Mol Cell Cardiol; 1990 Feb; 22(2):227-37. PubMed ID: 2109081
[TBL] [Abstract][Full Text] [Related]
11. Energy dependence of contraction band formation in perfused hearts and isolated adult myocytes.
Vander Heide RS; Angelo JP; Altschuld RA; Ganote CE
Am J Pathol; 1986 Oct; 125(1):55-68. PubMed ID: 3777140
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes.
Liu GS; Cohen MV; Mochly-Rosen D; Downey JM
J Mol Cell Cardiol; 1999 Oct; 31(10):1937-48. PubMed ID: 10525430
[TBL] [Abstract][Full Text] [Related]
13. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
[TBL] [Abstract][Full Text] [Related]
14. Comparison of in vitro preconditioning responses of isolated pig and rabbit cardiomyocytes: effects of a protein phosphatase inhibitor, fostriecin.
Armstrong SC; Kao R; Gao W; Shivell LC; Downey JM; Honkanen RE; Ganote CE
J Mol Cell Cardiol; 1997 Nov; 29(11):3009-24. PubMed ID: 9405176
[TBL] [Abstract][Full Text] [Related]
15. Alterations of ultrastructure and elemental composition in cultured neonatal rat cardiac myocytes after metabolic inhibition with iodoacetic acid.
Buja LM; Hagler HK; Parsons D; Chien K; Reynolds RC; Willerson JT
Lab Invest; 1985 Oct; 53(4):397-412. PubMed ID: 2413276
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of suppression of cardiac L-type Ca(2+) currents by the phospholipase A(2) inhibitor mepacrine.
Xiao YF; Zeind AJ; Kaushik V; Perreault-Micale CL; Morgan JP
Eur J Pharmacol; 2000 Jul; 399(2-3):107-16. PubMed ID: 10884509
[TBL] [Abstract][Full Text] [Related]
17. Effects of anoxic or oxygenated reperfusion in globally ischemic, isovolumic, perfused rat hearts.
Ganote CE; Humphrey SM
Am J Pathol; 1985 Jul; 120(1):129-45. PubMed ID: 4014439
[TBL] [Abstract][Full Text] [Related]
18. Sarcolemmal blebs and osmotic fragility as correlates of irreversible ischemic injury in preconditioned isolated rabbit cardiomyocytes.
Armstrong SC; Shivell LC; Ganote CE
J Mol Cell Cardiol; 2001 Jan; 33(1):149-60. PubMed ID: 11133231
[TBL] [Abstract][Full Text] [Related]
19. Effects of calcium loading and impaired energy production on metabolic and ultrastructural features of cell injury in cultured neonatal rat cardiac myocytes.
Buja LM; Fattor RA; Miller JC; Chien KR; Willerson JT
Lab Invest; 1990 Sep; 63(3):320-31. PubMed ID: 2168502
[TBL] [Abstract][Full Text] [Related]
20. Ca2+-antagonistic properties of phospholipase A2 inhibitors, mepacrine and chloroquine.
Filippov A; Skatova G; Porotikov V; Kobrinsky E; Saxon M
Gen Physiol Biophys; 1989 Apr; 8(2):113-8. PubMed ID: 2777057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
